This Startup Lets Paralyzed People Use Computers–Without A Chip In Their Head
Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...
Mitsubishi Tanabe Pharma America to Showcase New Research Findings in ALS at 2025 MDA Clinical and Scientific Conference
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025 Muscular Dystrophy Association ...
Cognixion Launches Clinical Trial for Late-Stage ALS to Deliver Conversation Level Communication with Adaptive AI-Driven Brain-Computer Interface
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic ...
ALS News Today24m
Legislation seeks access to benefits for spouses of veterans with ALS
Under current regulations, spouses can receive benefits only if the veteran lived with the disability for at least eight years before dying.
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
Fierce Biotech6d
Denali's ALS drug fails to redeem itself, missing key biomarker in trial extension
Denali Therapeutics’ amyotrophic lateral sclerosis (ALS) drug has racked up another clinical miss this year, leaving the ...
Study Finds on MSN1d
Researchers uncover serious flaw in promising Alzheimer’s blood tests
New research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...
Devdiscourse2h
AKGsOVIHAMS: Revolutionizing ALS Treatment with Integrative Medicine
AKGsOVIHAMS, a leading healthcare institution, has marked progress in treating ALS using integrative medicine. Known for combining conventional and alternative therapies, the institute has shown ...
Repurposed amyotrophic lateral sclerosis drug becomes imaging probe to help diagnose neurodegeneration
Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...
MedPage Today on MSN1d
Alzheimer's Research Funds in Limbo; X Chromosome and the Brain; Stress and Stroke
At least $65 million slated for 14 of 35 Alzheimer's disease research centers is in limbo, with funding expected to run out ...
Altoona Mirror9h
Driving force: Northern Bedford community rallies around longtime coach Crawford as he battles ALS
Despite being diagnosed with Amyotrophic Lateral Sclerosis, or ALS, a longtime coach at Northern Bedford County High School ...